Early onset basal cell carcinoma: Consider Bazex-Dupré-Christol syndrome.

Eur J Med Genet

Faculty of Medicine, University of Southampton, Southampton, UK; Wessex Clinical Genetics Service, Princess Anne Hospital, Coxford Road, Southampton, Hampshire, UK; Dermatology department, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, Hampshire, UK. Electronic address:

Published: February 2025

Bazex-Dupré-Christol syndrome is a rare genetic condition characterised by basal cell carcinomas, follicular atrophoderma and hypotrichosis. Until recently the molecular basis of the condition was largely unknown. A recent study has identified a section of duplicated DNA on the X chromosome of those with the condition which appears to be the underlying cause of the syndrome. This case study looks at a family with five affected members over three generations who had been diagnosed with the syndrome in early life and had previously undergone genetic testing with no cause being found. The index patient within this family has now been identified as having the same duplication as those tested in the initial study.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2025.105004DOI Listing

Publication Analysis

Top Keywords

basal cell
8
bazex-dupré-christol syndrome
8
early onset
4
onset basal
4
cell carcinoma
4
carcinoma consider
4
consider bazex-dupré-christol
4
syndrome
4
syndrome bazex-dupré-christol
4
syndrome rare
4

Similar Publications

Survey of the impact of BOLT-trial data on oncologists' and dermatologists' decision-making in treating patients with locally advanced basal cell carcinoma.

Dermatol Reports

February 2025

Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples.

Basal cell carcinoma (BCC) is the most common malignant tumor in white populations. Multiple studies demonstrated that the aberrant activation of Hedgehog signaling is a driver of BCC development, and its blockade represents a potential therapeutic target. In Italy, clinicians can prescribe Hedgehog inhibitors (HhIs) vismodegib and sonidegib.

View Article and Find Full Text PDF

Endometriosis and cancer risk.

Eur J Cancer Prev

March 2025

Department of Oncology and Hemato-Oncology, University of Milan.

Endometriosis is one of the most common gynecological benign disease. Epidemiological evidence suggests a potential association between endometriosis and cancer risk. Accumulating evidence highlighted the risk of ovarian cancer, particularly endometrioid and clear cell subtypes.

View Article and Find Full Text PDF

Eyelid and Canalicular Reconstruction in Peripunctal Tumors: Single-Center Experience Over Seven Years.

J Craniofac Surg

March 2025

Department of Oculoplastic Surgery, Beijing Tongren Eye Center, Beijing Tongren Hospital; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Capital Medical University, Beijing, China.

Study Design: Retrospective, noncomparative, and interventional case series.

Objective: Peripunctal tumors are uncommonly encountered. The management at the aesthetically and functionally sensitive area is demanding.

View Article and Find Full Text PDF

Diabetic foot ulcers (DFUs) are associated with a high risk of amputations and a 50% 5-year survival rate due at least in part to the limited angiogenic and wound healing capacity of patients with diabetes. Cell therapy via intramuscular injection of peripheral blood mononuclear cells showed encouraging but limited results. Such limitations may arise from the limited ability of therapeutic cells to adhere to the target tissue.

View Article and Find Full Text PDF

Reliable hexokinase 3 protein detection in human cell lines and primary tissue.

Eur J Histochem

January 2025

Institute of Tissue Medicine and Pathology; Graduate School for Cellular and Biomedical Sciences, University of Bern.

Accurate differentiation of homologous proteins that share high sequence identity remains a significant challenge in biomedical research, as conventional antibodies often lack sufficient specificity, leading to potential misinterpretations. This issue is particularly evident in the study of hexokinases, a family of isoenzymes that catalyze the first step of glycolysis by phosphorylating glucose. Beyond their canonical metabolic roles, hexokinases play critical non-glycolytic functions, especially in cancer biology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!